Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas: A Systematic Review and Meta-Analysis

2013 ◽  
Vol 91 (3) ◽  
pp. 291-296 ◽  
Author(s):  
Dong Fang ◽  
Xue-Song Li ◽  
Geng-Yan Xiong ◽  
Lin Yao ◽  
Zhi-Song He ◽  
...  
Keyword(s):  
Systematic Review ◽  
Urinary Tract ◽  
Meta Analysis ◽  
Upper Urinary Tract ◽  
Intravesical Chemotherapy ◽  
Bladder Tumors ◽  
Urothelial Carcinomas

The Prognostic Role of Ki-67/MIB-1 in Upper Urinary-Tract Urothelial Carcinomas: A Systematic Review and Meta-Analysis

2015 ◽  
Vol 29 (11) ◽  
pp. 1302-1308 ◽  
Author(s):  
Ye Lei ◽  
Zengbo Li ◽  
Lin Qi ◽  
Shiyu Tong ◽  
Bin Li ◽  
...  
Keyword(s):  
Systematic Review ◽  
Urinary Tract ◽  
Meta Analysis ◽  
Upper Urinary Tract ◽  
Prognostic Role ◽  
Ki 67 ◽  
Urothelial Carcinomas ◽  
Mib 1

Perioperative chemotherapy for urothelial carcinoma of the upper urinary tract: A systematic review and meta-analysis

2018 ◽  
Vol 128 ◽  
pp. 58-64 ◽  
Author(s):  
Richard W. Gregg ◽  
Francisco E. Vera-Badillo ◽  
Christopher M. Booth ◽  
Aamer Mahmud ◽  
Michael Brundage ◽  
...  
Keyword(s):  
Systematic Review ◽  
Urinary Tract ◽  
Urothelial Carcinoma ◽  
Meta Analysis ◽  
Upper Urinary Tract ◽  
Perioperative Chemotherapy

Prognostic Factors of Overall Survival in Upper Urinary Tract Carcinoma: A Systematic Review and Meta-analysis

Urology ◽  
2017 ◽  
Vol 100 ◽  
pp. 9-15 ◽  
Author(s):  
Fausto Petrelli ◽  
Mohamed Ismail Yasser Hussein ◽  
Ivano Vavassori ◽  
Sandro Barni
Keyword(s):  
Systematic Review ◽  
Overall Survival ◽  
Prognostic Factors ◽  
Urinary Tract ◽  
Meta Analysis ◽  
Upper Urinary Tract ◽  
Upper Urinary Tract Carcinoma

Ki-67 as a Prognostic Marker in Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis

2018 ◽  
Vol 16 (4) ◽  
pp. e831-e841 ◽  
Author(s):  
Chihyun Ahn ◽  
Chang Wook Jeong ◽  
Cheol Kwak ◽  
Hyeon Hoe Kim ◽  
Hyung Suk Kim ◽  
...  
Keyword(s):  
Systematic Review ◽  
Urinary Tract ◽  
Urothelial Carcinoma ◽  
Prognostic Marker ◽  
Meta Analysis ◽  
Upper Urinary Tract ◽  
Ki 67 ◽  
Urinary Tract Urothelial Carcinoma

Selective cytology in detection of high grade upper urinary tract urothelial cancer: A systematic review and meta-analysis

2019 ◽  
Vol 18 (1) ◽  
pp. e981
Author(s):  
M. Pones ◽  
M. Abufaraj ◽  
B. Förster ◽  
D. D’Andrea ◽  
F. Soria ◽  
...  
Keyword(s):  
Systematic Review ◽  
Urinary Tract ◽  
Urothelial Cancer ◽  
Meta Analysis ◽  
Upper Urinary Tract ◽  
High Grade

scholarly journals Diagnostic utility of axial imaging in the evaluation of hematuria: A systematic review and critical appraisal of the literature

2020 ◽  
Vol 15 (2) ◽  
Author(s):  
Christopher J.D. Wallis ◽  
Rashid K. Sayyid ◽  
Roni Manyevitch ◽  
Nathan Perlis ◽  
Vinata B. Lokeshwar ◽  
...  
Keyword(s):  
Systematic Review ◽  
Urinary Tract ◽  
Meta Analysis ◽  
Sampling Bias ◽  
Upper Urinary Tract ◽  
Risk Of Bias ◽  
Microscopic Hematuria ◽  
Gross Hematuria ◽  
Upper Tract ◽  
Tract Cancer

Introduction: Increasing severity of hematuria is instinctively associated with higher likelihood of urological malignancy. However, the robustness of the evidentiary base for this assertion is unclear, particularly as it relates to the likelihood of upper urinary tract pathology. Thus, the value of axial imaging in the diagnostic workup of hematuria is unclear due to differences in the underlying patient populations, raising concern for sampling bias. We performed a systematic review to characterize the literature and association between severity of hematuria and likelihood of upper urinary tract cancer based on axial imaging. Methods: MEDLINE, EMBASE, and Cochrane were systematically searched for all studies reporting on adult patients presenting with hematuria. We used Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) for reporting of this systematic review and meta-analysis and the Newcastle-Ottawa Scale for risk of bias assessment. Degree of hematuria was classified as “microscopic,” “gross,” or “unspecified.” Three urologic malignancies (bladder, upper tract urothelial, and renal cancer) were considered both individually and in aggregate. Random effects model with pairwise comparisons was employed to arrive at the axial imaging diagnostic yields. Results: Twenty-nine studies were included, of which six (20.7%) reported on patients with gross hematuria only, four (13.8%) reported on patients with microscopic hematuria only, seven (24.1%) included both, and 12 (41.4%) did not define or specify the severity of hematuria. Of 29 studies, two (6.9%) were at high-risk of bias, 21 (72.4%) at intermediate-risk, and six (20.7%) at low-risk of bias using the Newcastle-Ottawa criteria. Based on axial imaging, rates of diagnoses of renal, upper tract urothelial, and bladder cancers differed with differing severity of hematuria. Notably, rates of renal and upper tract urothelial carcinoma were higher in studies of patients with unspecified hematuria severity (3.6% and 10.4%, respectively) than among patients with gross hematuria (1.5% and 1.3%, respectively). When all urological malignancies were pooled, patients with unspecified hematuria were diagnosed more frequently (19.5%) compared to those with gross (15.3%) and microscopic hematuria (4.5%, difference = 1.51%; 99% confidence interval 3.6–26.5%). Conclusions: Lack of granularity in the available literature, particularly with regards to patients with unspecified hematuria severity, limits the generalizability of these results and highlights the need for future studies that provide sufficient baseline information allowing for firmer conclusions to be drawn.

Sign in / Sign up

Export Citation Format

Share Document